CNTG vs. ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, AONCW, AONC, APLMW, and ARTLW
Should you be buying Centogene stock or one of its competitors? The main competitors of Centogene include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), American Oncology Network (AONCW), American Oncology Network (AONC), Apollomics (APLMW), and Artelo Biosciences (ARTLW). These companies are all part of the "medical" sector.
180 Life Sciences (NASDAQ:ATNFW) and Centogene (NASDAQ:CNTG) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations.
180 Life Sciences has higher earnings, but lower revenue than Centogene.
Centogene received 40 more outperform votes than 180 Life Sciences when rated by MarketBeat users.
In the previous week, Centogene had 4 more articles in the media than 180 Life Sciences. MarketBeat recorded 6 mentions for Centogene and 2 mentions for 180 Life Sciences. Centogene's average media sentiment score of 1.88 beat 180 Life Sciences' score of 0.46 indicating that 180 Life Sciences is being referred to more favorably in the media.
9.9% of Centogene shares are held by institutional investors. 1.9% of Centogene shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Centogene has a consensus price target of $1.50, suggesting a potential upside of 265.85%. Given 180 Life Sciences' higher possible upside, analysts clearly believe Centogene is more favorable than 180 Life Sciences.
Summary
Centogene beats 180 Life Sciences on 6 of the 7 factors compared between the two stocks.
Get Centogene News Delivered to You Automatically
Sign up to receive the latest news and ratings for CNTG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Centogene Competitors List
Related Companies and Tools
